Tachycardia-induced cardiomyopathy
- PMID: 23001096
- PMCID: PMC4543895
- DOI: 10.1136/bcr-2012-006587
Tachycardia-induced cardiomyopathy
Abstract
Tachycardia-induced cardiomyopathy (TIC) is an important cause of heart failure as it is potentially reversible after ventricular rate control. A 66-year-old hypertensive woman presented with a 15-day history of tachycardia, dyspnoea and oedema. ECG revealed atrial fibrillation with ventricular frequency of 130 beats per minute (bpm). Echocardiogram showed dilated left ventricle (LV) with 0.39 ejection fraction. Angiography revealed non-obstructed coronary arteries. Heart rate and cardiac failure were controlled with amiodarone, digoxine, captopril, metoprolol and furosemide. During follow-up, despite drug dose optimisation, the patient kept complaining of tachycardia and dyspnoea with a ventricular rate between 108 and 120 bpm. Medical staff suspected she was not taking her medicines properly. Two months later, the patient was asymptomatic and had converted to sinus rhythm (heart rate of 76 bpm). Echocardiogram showed normal LV size and function. Patient's diagnosis was TIC. Although rare, TIC should be considered in all cases of systolic dysfunction associated with tachyarrhythmia.
Figures
References
-
- Umana E, Solares CA, Alpert MA. Tachycardia-induced cardiomyopathy. Am J Med 2003;114:51–5. - PubMed
-
- Lip GY, Tse HF, Lane DA. Atrial fibrillation. Lancet 2012;379:648–61. - PubMed
-
- Fujino T, Yamashita T, Suzuki S, et al. Characteristics of congestive heart failure accompanied by atrial fibrillation with special reference to tachycardia-induced cardiomyopathy. Circ J 2007;71:936–40. - PubMed
-
- Lishmanov A, Chockalingam P, Senthilkumar A, et al. Tachycardia-induced cardiomyopathy: evaluation and therapeutic options. Congest Heart Fail 2010;16:122–6. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources